| Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer (NCT04399824) | Jonsson Comprehensive Cancer Center | 2020-04-03 |
| Brain Health in Breast Cancer Survivors (NCT04297020) | Jonsson Comprehensive Cancer Center | 2020-03-11 |
| Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma (NCT04205838) | Jonsson Comprehensive Cancer Center | 2020-03-04 |
| Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer (NCT04742608) | Jonsson Comprehensive Cancer Center | 2020-02-21 |
| Focal Laser Ablation of Prostate Cancer (NCT04305925) | Jonsson Comprehensive Cancer Center | 2020-01-30 |
| Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma (NCT04106362) | Jonsson Comprehensive Cancer Center | 2020-01-14 |
| Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma (NCT04201873) | Jonsson Comprehensive Cancer Center | 2020-01-08 |
| Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma (NCT03014804) | Jonsson Comprehensive Cancer Center | 2019-12-01 |
| Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups (NCT06090643) | Jonsson Comprehensive Cancer Center | 2019-11-01 |
| Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors (NCT03953157) | Jonsson Comprehensive Cancer Center | 2019-10-07 |
| Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases (NCT04069910) | Jonsson Comprehensive Cancer Center | 2019-08-26 |
| Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer (NCT03970252) | Jonsson Comprehensive Cancer Center | 2019-07-24 |
| CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia (NCT03904251) | Jonsson Comprehensive Cancer Center | 2019-07-18 |
| Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted (NCT04185311) | Jonsson Comprehensive Cancer Center | 2019-07-10 |
| CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer (NCT03546361) | Jonsson Comprehensive Cancer Center | 2019-07-08 |
| Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer (NCT04282824) | Jonsson Comprehensive Cancer Center | 2019-06-05 |
| Pembrolizumab in Treating Participants With Leukoplakia (NCT03603223) | Jonsson Comprehensive Cancer Center | 2019-05-03 |
| Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery (NCT03515577) | Jonsson Comprehensive Cancer Center | 2019-04-12 |
| SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer (NCT03411070) | Jonsson Comprehensive Cancer Center | 2019-04-07 |
| Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma (NCT03623854) | Jonsson Comprehensive Cancer Center | 2019-04-03 |
| Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer (NCT03892720) | Jonsson Comprehensive Cancer Center | 2019-03-27 |
| Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer (NCT03732950) | Jonsson Comprehensive Cancer Center | 2019-03-06 |
| Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy (NCT03830918) | Jonsson Comprehensive Cancer Center | 2019-03-06 |
| Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery (NCT03541850) | Jonsson Comprehensive Cancer Center | 2019-01-29 |
| Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate (NCT03582475) | Jonsson Comprehensive Cancer Center | 2019-01-11 |
| OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects (NCT04069923) | Jonsson Comprehensive Cancer Center | 2018-12-18 |
| Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer (NCT03745690) | Jonsson Comprehensive Cancer Center | 2018-12-12 |
| SPECT/CT for the Characterization of Renal Masses (NCT03996850) | Jonsson Comprehensive Cancer Center | 2018-12-07 |
| 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma (NCT03732352) | Jonsson Comprehensive Cancer Center | 2018-11-28 |
| Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer (NCT03672773) | Jonsson Comprehensive Cancer Center | 2018-10-31 |
| Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer (NCT03601455) | Jonsson Comprehensive Cancer Center | 2018-10-26 |
| Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) (NCT02756130) | Jonsson Comprehensive Cancer Center | 2018-08-01 |
| Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy (NCT03582774) | Jonsson Comprehensive Cancer Center | 2018-07-12 |
| TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma (NCT03506802) | Jonsson Comprehensive Cancer Center | 2018-07-10 |
| Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma (NCT03425461) | Jonsson Comprehensive Cancer Center | 2018-06-14 |
| Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy (NCT03596710) | Jonsson Comprehensive Cancer Center | 2018-06-14 |
| PET Imaging of the Immune System Using Analog Probes (NCT03409419) | Jonsson Comprehensive Cancer Center | 2018-04-10 |
| 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer (NCT04050215) | Jonsson Comprehensive Cancer Center | 2018-04-02 |
| Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy (NCT02597894) | Jonsson Comprehensive Cancer Center | 2018-03-01 |
| Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer (NCT02881242) | Jonsson Comprehensive Cancer Center | 2018-01-30 |
| Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy (NCT03148327) | Jonsson Comprehensive Cancer Center | 2017-10-11 |
| Hemi-Gland Cryoablation for Prostate Cancer at UCLA (NCT03503643) | Jonsson Comprehensive Cancer Center | 2017-09-14 |
| FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma (NCT01410630) | Jonsson Comprehensive Cancer Center | 2017-09-07 |